Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
776.15
Change Change %
-13.30 -1.68%

Updated:18 Sep, 2018, 15:59 PM IST

BSE
776.60
Change Change %
-13.30 -1.68%

Updated:18 Sep, 2018, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Bank of America Merrill Lynch
N/A
11-08-2014 Buy 753.25 915.00
N/A
Target Hit Long (1Y)
11-08-2015

Bank of America Merrill Lynch maintains buy on Aurobindo Pharma

Raising FY15 and FY16 earnings per share estimates by 5 per cent and 4 per cent. US sales hit an all-time high of $187 million in the June quarter. Improving profitability will continue to drive re-rating. Expect margins to remain at 23-24 per cent levels.

Top